Table 2

P values for treatment-by-subgroup interaction analyses

Q6MQ3M
Swollen joint count0.4020.553
Tender joint count0.9790.696
CRP0.8150.946
ESR0.6920.696
Glucocorticoid use0.1740.075
RF status0.2660.454
Anti-CCP antibodies0.1930.029
Baseline mTSS0.5870.154
Baseline ES0.2410.063
  • CCP, cyclic citrullinated peptide; CRP, C reactive protein; ES, bone erosion score; ESR, erythrocyte sedimentation rate; mTSS, modified total Sharp score; Q3M, denosumab 60 mg every 3¬†months; Q6M, denosumab 60 mg every 6¬†months; RF, rheumatoid factor.